All In Biotech

Drug Trial Radar · NCT01084824

A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin

A Randomized Clinical Trial Examining the Efficacy of Treatment of Cutaneous Verruca Vulgaris in Adult Patients With Combined Liquid Nitrogen Cryotherapy and Topically Applied Cantharidin

Last checked: Nov 19, 2026Latest source record: Mar 11, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

70

Actual

Start

Jun 2007

Primary completion

Jun 2008

Study completion Sep 2008

Sponsor

Lead sponsor
North Idaho DermatologyAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 11, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study was to see if liquid nitrogen, a commonly used treatment for warts, is more effective if it is used alone, or if it is more effective if combined with cantharidin, a topical treatment also commonly used for warts (verruca vulgaris).

Conditions

  • Verruca Vulgaris

Interventions

  • Liquid nitrogen and cantharidinDrug

    Liquid nitrogen applied to wart(s), then cantharidin 1% topical applied afterward.

  • Liquid nitrogen and topical placeboDrug

    Liquid nitrogen applied to wart(s), then placebo vehicle applied thereafter.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of common warts clearedTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • North Idaho Dermatology

    Coeur d'Alene, Idaho

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.